The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

K.V. Maksimov

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

M.V. Starkova

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

D.V. Bagdasarova

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

N.N. Volchenko

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

M.L. Mazo

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

V.S. Surkova

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

A.D. Zikiryakhodzhaev

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Russia;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Russia;
Peoples’ Friendship University of Russia

Can surgical treatment in the future be abandoned in breast cancer patients with a complete morphopathological response after neoadjuvant chemotherapy?

Authors:

K.V. Maksimov, M.V. Starkova, D.V. Bagdasarova, N.N. Volchenko, M.L. Mazo, V.S. Surkova, A.D. Zikiryakhodzhaev

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2022;11(6): 73‑79

Views: 724

Downloaded: 6


To cite this article:

Maksimov KV, Starkova MV, Bagdasarova DV, Volchenko NN, Mazo ML, Surkova VS, Zikiryakhodzhaev AD. Can surgical treatment in the future be abandoned in breast cancer patients with a complete morphopathological response after neoadjuvant chemotherapy? P.A. Herzen Journal of Oncology. 2022;11(6):73‑79. (In Russ.)
https://doi.org/10.17116/onkolog20221106173

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.